Sawtooth Solutions, LLC Vista Gen Therapeutics, Inc. Transaction History

Sawtooth Solutions, LLC

  • $3.64 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023
BUY
$0.12 - $0.3 $62 - $156
521 Added 3.58%
15,073 $1,000
Q4 2022

Feb 02, 2023
SELL
$0.09 - $4.8 $0 - $48
-10 Reduced 0.07%
14,552 $1,000
Q3 2022

Oct 12, 2022
BUY
$0.14 - $4.8 $2,038 - $69,897
14,562 New
14,562 $2,000

Others Institutions Holding VTGN

# of Institutions
2
Shares Held
2.7M
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $610M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email